The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Pevzner A.M.

Tomsk National Research Medical Center of the Russian Academy of Sciences, Oncology Research Institute, Tomsk, Russia

Tsyganov M.M.

Tomsk National Research Medical Center of the Russian Academy of Sciences, Oncology Research Institute, Tomsk, Russia

Ibragimova M.K.

Tomsk National Research Medical Center of the Russian Academy of Sciences, Oncology Research Institute, Tomsk, Russia

Litvyakov N.V.

Tomsk Research Institute of Oncology, Tomsk, Russia, 634050;
Tomsk National Research University, Tomsk, Russia, 634050

Viral co-infection with head and neck tumors

Authors:

Pevzner A.M., Tsyganov M.M., Ibragimova M.K., Litvyakov N.V.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2020;85(2): 67‑72

DOI: 10.17116/otorino20208502167

Views: 1674

Downloaded: 64

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Pevzner AM, Tsyganov MM, Ibragimova MK, Litvyakov NV. Viral co-infection with head and neck tumors. Russian Bulletin of Otorhinolaryngology. 2020;85(2):67‑72. (In Russ.)
https://doi.org/10.17116/otorino20208502167

Подписка 2025 (Russian Bulletin of Otorhinolaryngology)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Oppo­rtunities of patient-oriented systems for digi­tal prevention of chro­nic non-communicable diseases. Russian Journal of Preventive Medi­cine. 2024;(6):7-13
New viral infe­ctions — new challenges. Russian Journal of Preventive Medi­cine. 2024;(7):114-119
Modern aspe­cts of etiopathogenesis, diagnosis and treatment of lipe­dema. Plastic Surgery and Aesthetic Medi­cine. 2024;(3):86-92
Improvement of therapy of papi­llomavirus infe­ction latent forms. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):575-580
Immu­nology of the cervix in normal and pathological conditions (literature review). Russian Journal of Human Reproduction. 2024;(5):108-117

The review is devoted to assessing the prevalence of human papillomavirus (HPV) in combination with other viral agents for head and neck tumors (HNT). HPV is recognized as an etiological factor in the development of cervical cancer, but there is evidence that it may be involved in carcinogenesis in other locations, in particular the upper respiratory tract. However, HPV is not the most important factor in tumor growth and progression. Recently, many researchers have reported the presence of concomitant co-infection, affecting tumor progression. Of all the studies analyzed, only 3 studies showed the absence or low rates of co-infection in HNT: from the Czech Republic (0%), China (0.6%) and Japan (3%). Most often, HPV infection was detected together with the Epstein-Barr virus (EBV) — from 12.5 to 34.1% of cases. In Russia, the prevailing combination of viral co-infection was a combination of EBV and cytomegalovirus (9.5%) and a combination of EBV and herpes simplex virus (6.7%). Thus, the degree of incidence of HPV in HNT varies greatly, and the mechanisms of coinfection are poorly understood, which raises the question of whether HPV and concomitant infection can be involved in tumor progression. This makes further research in this direction relevant and promising.

Keywords:

tumors of the head and neck
co-infection
human papillomavirus
overview

Authors:

Pevzner A.M.

Tomsk National Research Medical Center of the Russian Academy of Sciences, Oncology Research Institute, Tomsk, Russia

Tsyganov M.M.

Tomsk National Research Medical Center of the Russian Academy of Sciences, Oncology Research Institute, Tomsk, Russia

Ibragimova M.K.

Tomsk National Research Medical Center of the Russian Academy of Sciences, Oncology Research Institute, Tomsk, Russia

Litvyakov N.V.

Tomsk Research Institute of Oncology, Tomsk, Russia, 634050;
Tomsk National Research University, Tomsk, Russia, 634050

List of references:

  1. Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. Journal of Clinical Virology. 2005;32(1):59-66. https://doi.org/10.1016/j.jcv.2004.11.017
  2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2015;136(5):359-386. https://doi.org/10.1002/ijc.29210
  3. Paches AI. Opukholi golovy i shei. Klinicheskoe rukovodstvo. M.: Prakticheskaya meditsina. 2013:170.
  4. Ridge JA, Glisson BS, Lango MN, Feigenberg S. Head and neck tumors. Cancer Management: A Multidisciplinary Approach. 2008; 11(3):369-408.
  5. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. Journal of Clinical Oncology. 2015;33(29):3235-3242. https://doi.org/10.1200/JCO.2015.61.6995
  6. Aaro T, Jaana R, Reidar G, Kari S, Stina S. Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas. Oncotarget. 2017;8(16):27328-27338. https://doi.org/10.18632/oncotarget.16033
  7. De Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. The Lancet Oncology. 2012;13(6): 607-615. https://doi.org/10.1016/S1470-2045(12)70137-7
  8. Dayyani F, Etzel CJ, Liu M, Ho C-H, Lippman SM, Tsao AS. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head & Neck Oncology. 2010;2(1):1-11. https://doi.org/10.1186/1758-3284-2-15
  9. Mehanna H, Beech T, Nicholson T, El‐Hariry I, Mcconkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer — systematic review and meta‐analysis of trends by time and region. Head & Neck. 2013;35(5):747-755. https://doi.org/10.1002/hed.22015
  10. Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, et al. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988—2007). Annals of Oncology. 2008;19(10):1681-1690. https://doi.org/10.1093/annonc/mdn372
  11. Acharya S, Ekalaksananan T, Vatanasapt P, Loyha K, Phusingha P, Promthet S et al. Association of Epstein‐Barr virus infection with oral squamous cell carcinoma in a case-control study. Journal of Oral Pathology & Medicine. 2015;44(4):252-257. https://doi.org/10.1111/jop.12231
  12. Jalouli J, Jalouli MM, Sapkota D, Ibrahim SO, Larsson P-A, Sand L. Human papilloma virus, herpes simplex virus and Epstein-Barr virus in oral squamous cell carcinoma from eight different countries. Anticancer Research. 2012;32(2):571-580.
  13. Deng Z, Uehara T, Maeda H, Hasegawa M, Matayoshi S, Kiyuna A, et al. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers. PLoS One. 2014;9(11):e113702. https://doi.org/10.1371/journal.pone.0113702
  14. De Oliveira DE. DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Letters. 2007;247(2):182-196. https://doi.org/10.1016/j.canlet.2006.05.010
  15. Rickinson A. Co-infections, inflammation and oncogenesis: future directions for EBV research. Seminars in Cancer Biology. 2014; 26(1):99-115. https://doi.org/10.1016/j.semcancer.2014.04.004
  16. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. Journal of the National Cancer Institute. 2000;92(9):709-720. https://doi.org/10.1093/jnci/92.9.709
  17. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. New England Journal of Medicine. 2010; 363(1):24-35. https://doi.org/10.1056/NEJMoa0912217
  18. Sekee TR, Burt FJ, Goedhals D, Goedhals J, Munsamy Y, Seedat RY. Human papillomavirus in head and neck squamous cell carcinomas in a South African cohort. Papillomavirus Research. 2018;6(1):58-62. https://doi.org/10.1016/j.pvr.2018.10.006 19. Malaria and some polyomaviruses (SV40, BK, JC, and Merkel cell viruses). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: WHO. 2013;133-214.
  19. Drop B, Strycharz-Dudziak M, Kliszczewska E, Polz-Dacewicz M. Coinfection with Epstein-Barr Virus (EBV), Human Papilloma Virus (HPV) and Polyoma BK Virus (BKPyV) in Laryngeal, Oropharyngeal and Oral Cavity Cancer. International Journal of Molecular Sciences. 2017;18(12):2752. https://doi.org/10.3390/ijms18122752
  20. Polz-Gruszka D, Morshed K, Jarzyński A, Polz-Dacewicz M. Prevalence of Polyoma BK virus (BKPyV), Epstein-Barr virus (EBV) and Human Papilloma virus (HPV) in oropharyngeal cancer. Pol J Microbiol. 2015;64(1):323-328.
  21. Huang WB, Chan JYW, Liu DL. Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: multicenter study from an endemic area in Southern China. Cancer. 2018;124(3):530-536. https://doi.org/10.1002/cncr.31031
  22. Vazquez-Guillen JM, Palacios-Saucedo GC, Rivera-Morales LG, Alonzo-Morado MV, Burciaga-Bernal SB, Montufar-Martinez M, et al. Infection and coinfection by human papillomavirus, Epstein-Barr virus and Merkel cell polyomavirus in patients with squamous cell carcinoma of the larynx: a retrospective study. PeerJ. 2018;6(1):e5834. https://doi.org/10.7717/peerj.5834
  23. Kano M, Kondo S, Wakisaka N, Moriyama-Kita M, Nakanishi Y, Endo K, et al. The influence of human papillomavirus on nasopharyngeal carcinoma in Japan. Auris Nasus Larynx. 2017; 44(3):327-332. https://doi.org/10.1016/j.anl.2016.07.015
  24. Svajdler JM, Kaspirkova J, Mezencev R, Laco J, Torday T, Dubinsky P, et al. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population. Neoplasma. 2016;63(1):107-114. https://doi.org/10.4149/neo_2016_013
  25. Rautava J, Kuuskoski J, Syrjänen K, Grenman R, Syrjänen S. HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas. Journal of Clinical Virology. 2012;53(2):116-120. https://doi.org/10.1016/j.jcv.2011.11.005
  26. Mclemore MS, Haigentz M, Smith RV, Nuovo GJ, Alos L, Cardesa A, et al. Head and neck squamous cell carcinomas in HIV-positive patients: a preliminary investigation of viral associations. Head and Neck Pathology. 2010;4(2):97-105. https://doi.org/10.1007/s12105-010-0171-9
  27. Polz-Gruszka D, Stec A, Dworzański J, Polz-Dacewicz M. EBV, HSV, CMV and HPV in laryngeal and oropharyngeal carcinoma in Polish patients. Anticancer Research. 2015;35(3):1657-1661.
  28. Kucherova LR, Katinas EB. Vyyavlenie khronicheskoj virusnoj infektsii metodom polimerazno-tsepnoj reaktsii pri proliferativnykh zabolevaniyakh gortani. Rossijskaya otorinolaringologiya. 2010; 1(44):62-66. (In Russ.)
  29. Svetitsky PV, Zlatnik EYu, Zykova TA, Nistratov GP, Aedinova IV, Volkova VL, et al. Techenie raka organov polosti rta s uchetom assotsiirovannosti s virusom Epshteyna—Barr, papillomy cheloveka i urovnya nekotorykh tsitokinov. Mezhdunarodnyj zhurnal prikladnykh i fundamental’nykh issledovanij. 2014;11(1):120-122. (In Russ.)
  30. Nistratov GP, Svetitsky PV, Zykova TA, Aedinova IV, Volkova VL, Bauzhadze MV, et al. Vliyanie virusov Epshteyna—Barr i papillomy cheloveka na techenie raka organov polosti rta. Sovremennye problemy nauki i obrazovaniya. 2014;6(1):1-8. (In Russ.)
  31. Adams PD. Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Molecular cell. 2009;36(1):2-14. https://doi.org/10.1016/j.molcel.2009.09.021
  32. Nichols WW. Virus-induced chromosome abnormalities. Annual Reviews in Microbiology. 1970;24(1):479-500. https://doi.org/10.1146/annurev.mi.24.100170.002403
  33. Schmid H.P., Evolutionary parasitologythe integrated study of infections, immunology, ecology, and genetics. Oxford. Oxford University Press. 2011; 516.
  34. Hutt-Fletcher LM. Epstein-Barr virus entry. Journal of Virology. 2007;81(15):7825-7832. https://doi.org/10.1128/JVI.00445-07
  35. Du X-J, Tang L-L, Mao Y-P, Guo R, Sun Y, Lin A-H, et al. Circulating EBV DNA, globulin and nodal size predict distant metastasis after intensity-modulated radiotherapy in stage II nasopharyngeal carcinoma. Journal of Cancer. 2016;7(6):664-670. https://doi.org/10.7150/jca.14183
  36. Jiang R, Gu X, Nathan CA, Hutt‐Fletcher L. Laser‐capture microdissection of oropharyngeal epithelium indicates restriction of Epstein—Barr virus receptor/CD21 mRNA to tonsil epithelial cells. Journal of Oral Pathology & Medicine. 2008;37(10):626-633. https://doi.org/10.1111/j.1600-0714.2008.00681.x
  37. Longnecker RM, Kieff E, Cohen JI. Epstein-Barr virus. In: DM Knipe, PM Howley, JI Cohen, DE Griffith, RA Lamb, MA Martin, et al. (eds). Fields Virology. Philadelphia: Lippincott Williams & Wilkins. 2013:1898-1959.
  38. Jiang R, Ekshyyan O, Moore‐Medlin T, Rong X, Nathan S, Gu X, et al. Association between human papilloma virus / Epstein-Barr virus coinfection and oral carcinogenesis. Journal of Oral Pathology & Medicine. 2015;44(1):28-36. https://doi.org/10.1111/jop.12221
  39. Tsang CM, Yip YL, Lo KW, Deng W, To KF, Hau PM, et al. Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells. Proceedings of the National Academy of Sciences. 2012;109(50):3473-3482. https://doi.org/10.1073/pnas.1202637109
  40. Perez R, Gibson S, Lopez P, Koenig E, De Castro M, Yamamura Y. Distribution of HIV-1 infection in different T lymphocyte subsets: antiretroviral therapy-naive vs. experienced patients. AIDS research and human retroviruses. 2011;27(4):399-410. https://doi.org/10.1089/aid.2010.0176
  41. Reusser N, Downing C, Guidry J, Tyring S. HPV carcinomas in immunocompromised patients. Journal of Clinical Medicine. 2015;4(2):260-281. https://doi.org/10.3390/jcm4020260
  42. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathogens. 2010;6(4):e1000852. https://doi.org/10.1371/journal.ppat.1000852
  43. D’Souza G, Carey TE, William WN Jr, Nguyen ML, Ko EC, Riddell J 4th, et al. Epidemiology of head and neck squamous cell cancer among HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes (1999). 2014;65(5):603. https://doi.org/10.1097/QAI.0000000000000083
  44. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Malaria and Some Polyomaviruses (SV40, BK, JC, and Merkel Cell Viruses). IARC monographs on the evaluation of carcinogenic risks to humans. 2014;104:9-350.
  45. Schowalter RM, Reinhold WC, Buck CB. Entry tropism of BK and Merkel cell polyomaviruses in cell culture. PLoS One. 2012; 7(7):e42181. https://doi.org/10.1371/journal.pone.0042181
  46. Büning H, Schmidt M. Adeno-associated vector toxicity — to be or not to be? Molecular Therapy. 2015;23(11):1673-1675. https://doi.org/10.1038/mt.2015.182
  47. Hermonat P, Plott R, Santin A, Parham G, Flick J. Adeno-Associated Virus Rep78 Inhibits Oncogenic Transformation of Primary Human Keratinocytes by a Human Papillomavirus Type 16-ras Chimeric. Gynecologic Oncology. 1997;66(3):487-494. https://doi.org/10.1006/gyno.1997.4789
  48. Strickler HD, Viscidi R, Escoffery C, Rattray C, Kotloff KL, Goldberg J, et al. Adeno‐associated virus and development of cervical neoplasia. Journal of Medical Virology. 1999;59(1):60-65. https://doi.org/10.1002/(SICI)1096-9071(199909)59:1<60::AID-JMV10>3.0.CO;2-8
  49. Walz C, Anisi T, Schlehofer J, Gissmann L, Schneider A, Müller M. Detection of infectious adeno-associated virus particles in human cervical biopsies. Virology. 1998;247(1):97-105. https://doi.org/10.1006/viro.1998.9226

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.